Skip to content
PIL Logo

Buprenorphine 2.0mg Sublingual Tablets

Last Updated on eMC 03-Mar-2016 View document  | Thornton & Ross Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03-Mar-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - how to take/use
  • Change to section 3 - duration of treatment
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product looks like and pack contents

Updated on 26-Mar-2015 and displayed until 03-Mar-2016

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Thornton & Ross Ltd

Company image

Linthwaite, Huddersfield, West Yorks, HD7 5QH

Medical Information e-mail
Medical Information Direct Line

+44 (0) 1484 848164

Customer Care direct line

+44(0)1484 848200

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

buprenorphine hydrochloride

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue